Prevention of restenosis after coronary balloon angioplasty: Rationale and design of the fluvastatin angioplasty restenosis (FLARE) trial
- 26 May 1994
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 73 (14) , D50-D61
- https://doi.org/10.1016/0002-9149(94)90633-5
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Restenosis revisited: Insights provided by quantitative coronary angiographyAmerican Heart Journal, 1993
- HMG CoA reductase inhibitors. In vivo effects on carotid intimal thickening in normocholesterolemic rabbits.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
- Calibration using angiographic catheters as scaling devices — Importance of filming the catheters not filled with contrast mediumThe American Journal of Cardiology, 1992
- Prevention of restenosis after percutaneous transluminal coronary angioplasty: The search for a “magic bullet”American Heart Journal, 1991
- Prevention of restenosis by lovastatin after successful coronary angioplastyAmerican Heart Journal, 1991
- Regulation of the mevalonate pathwayNature, 1990
- HMG-CoA Reductase Inhibitors for Treatment of HypercholesterolemiaNew England Journal of Medicine, 1988
- The Pathogenesis of Atherosclerosis — An UpdateNew England Journal of Medicine, 1986
- The value of lesion cross-sectional area determined by quantitative coronary angiography in assessing the physiologic significance of proximal left anterior descending coronary arterial stenoses.Circulation, 1984
- Percutaneous transluminal coronary angioplasty. The first five years and the futureInternational Journal of Cardiology, 1983